Skip to main content
Top
Published in: Medical Oncology 5/2020

01-05-2020 | Breast Cancer | Original Paper

Cellular apoptosis susceptibility protein (CAS) suppresses the proliferation of breast cancer cells by upregulated cyp24a1

Authors: Mei Ye, Ruigang Han, Jianwu Shi, Xunda Wang, Allan Z. Zhao, Fanghong Li, Hao Chen

Published in: Medical Oncology | Issue 5/2020

Login to get access

Abstract

Breast cancer is the most common cancer in women. Although several studies demonstrated cellular apoptosis susceptibility protein (CAS) involved in the development of breast cancer, the underlying mechanisms of CAS regulating cell processes in the breast cancer remain elusive. In the present study, we explored the possible mechanism of CAS in contributing to the cell proliferation in the breast cancer cell line MCF-7. Knockdown of CAS led to the reduction of cell viability and proliferation. Furthermore, cell cycle was arrested in G0/G1 phase after knocking down CAS with the decrease of cyclinD1. In addition, RNA-seq analysis for the CAS knockdown cells demonstrated that total eleven genes were significantly altered (Fold changes > 2). Of note, the expression of cyp24a1 was dramatically increased in the shCAS cells compared to that of shNC cells as well as confirmed by quantitative real-time polymerase chain reaction (qPCR). These observations clarified the previous conflicting results on the cell fates of the breast cells regulated by CAS and provide new insight into the role of CAS in the development of breast cancer.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bray F, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. Bray F, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
2.
go back to reference Zhan C, Zhang XY, Pang D. High expression of CSE1L is associated with poor prognosis in breast cancer. Int J Clin Exp Pathol. 2016;9(11):11788–94. Zhan C, Zhang XY, Pang D. High expression of CSE1L is associated with poor prognosis in breast cancer. Int J Clin Exp Pathol. 2016;9(11):11788–94.
3.
go back to reference Yuksel UM, et al. Does CSE1L overexpression affect distant metastasis development in breast cancer? Oncol Res Treat. 2015;38(9):431–4.PubMed Yuksel UM, et al. Does CSE1L overexpression affect distant metastasis development in breast cancer? Oncol Res Treat. 2015;38(9):431–4.PubMed
4.
go back to reference Lee WR, et al. CSE1L Links cAMP/PKA and Ras/ERK pathways and regulates the expressions and phosphorylations of ERK1/2, CREB, and MITF in melanoma cells. Mol Carcinog. 2016;55(11):1542–52.PubMed Lee WR, et al. CSE1L Links cAMP/PKA and Ras/ERK pathways and regulates the expressions and phosphorylations of ERK1/2, CREB, and MITF in melanoma cells. Mol Carcinog. 2016;55(11):1542–52.PubMed
5.
go back to reference Cheng DD, et al. CSE1L interaction with MSH6 promotes osteosarcoma progression and predicts poor patient survival. Sci Rep. 2017;7(1):1–13. Cheng DD, et al. CSE1L interaction with MSH6 promotes osteosarcoma progression and predicts poor patient survival. Sci Rep. 2017;7(1):1–13.
6.
go back to reference Qin LX, Tang ZY. The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol. 2002;8(3):385–92.PubMedPubMedCentral Qin LX, Tang ZY. The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol. 2002;8(3):385–92.PubMedPubMedCentral
7.
go back to reference Shiraki K, et al. Cellular apoptosis susceptibility protein and proliferation in human hepatocellular carcinoma. Int J Mol Med. 2006;18(1):77–81.PubMed Shiraki K, et al. Cellular apoptosis susceptibility protein and proliferation in human hepatocellular carcinoma. Int J Mol Med. 2006;18(1):77–81.PubMed
8.
go back to reference Winkler J, et al. Cellular apoptosis susceptibility (CAS) is linked to integrin β1 and required for tumor cell migration and invasion in hepatocellular carcinoma (HCC). Oncotarget. 2016;7(16):22883–92.PubMedPubMedCentral Winkler J, et al. Cellular apoptosis susceptibility (CAS) is linked to integrin β1 and required for tumor cell migration and invasion in hepatocellular carcinoma (HCC). Oncotarget. 2016;7(16):22883–92.PubMedPubMedCentral
9.
go back to reference Liu GM, et al. Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma. Cancer Cell Int. 2019;19:138.PubMedPubMedCentral Liu GM, et al. Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma. Cancer Cell Int. 2019;19:138.PubMedPubMedCentral
10.
go back to reference Pimiento JM, et al. Knockdown of cse1l gene in colorectal cancer reduces tumorigenesis in vitro. Am J Pathol. 2016;186(10):2761–8.PubMedPubMedCentral Pimiento JM, et al. Knockdown of cse1l gene in colorectal cancer reduces tumorigenesis in vitro. Am J Pathol. 2016;186(10):2761–8.PubMedPubMedCentral
11.
go back to reference Jiang MC, et al. CSE1L modulates Ras-induced cancer cell invasion: correlation of K-Ras mutation and CSE1L expression in colorectal cancer progression. Am J Surg. 2013;206(3):418–27.PubMed Jiang MC, et al. CSE1L modulates Ras-induced cancer cell invasion: correlation of K-Ras mutation and CSE1L expression in colorectal cancer progression. Am J Surg. 2013;206(3):418–27.PubMed
12.
go back to reference Tai CJ, Su TC, Jiang MC. Correlations between cytoplasmic CSE1L in neoplastic colorectal glands and depth of tumor penetration and cancer stage. J Transl Med. 2013;11:29.PubMedPubMedCentral Tai CJ, Su TC, Jiang MC. Correlations between cytoplasmic CSE1L in neoplastic colorectal glands and depth of tumor penetration and cancer stage. J Transl Med. 2013;11:29.PubMedPubMedCentral
13.
go back to reference Tsao TY, et al. Function of CSE1L/CAS in the secretion of HT-29 human colorectal cells and its expression in human colon. Mol Cell Biochem. 2009;327(1–2):163–70.PubMed Tsao TY, et al. Function of CSE1L/CAS in the secretion of HT-29 human colorectal cells and its expression in human colon. Mol Cell Biochem. 2009;327(1–2):163–70.PubMed
14.
go back to reference Sillars-Hardebol AH, et al. TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression. Gut. 2012;61(11):1568–75.PubMed Sillars-Hardebol AH, et al. TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression. Gut. 2012;61(11):1568–75.PubMed
15.
go back to reference Li KK, et al. MIR-137 suppresses growth and invasion, is downregulated in oligodendroglial tumors and targets CSE1L. Brain Pathol. 2013;23(4):426–39.PubMed Li KK, et al. MIR-137 suppresses growth and invasion, is downregulated in oligodendroglial tumors and targets CSE1L. Brain Pathol. 2013;23(4):426–39.PubMed
16.
17.
go back to reference Liu J, et al. Expression of cellular apoptosis susceptibility (CAS) in the human testis and testicular germ cell tumors. Med Oncol. 2019;36(7):61.PubMed Liu J, et al. Expression of cellular apoptosis susceptibility (CAS) in the human testis and testicular germ cell tumors. Med Oncol. 2019;36(7):61.PubMed
18.
go back to reference Lorenzato A, et al. The cellular apoptosis susceptibility CAS/CSE1L gene protects ovarian cancer cells from death by suppressing RASSF1C. FASEB J. 2012;26(6):2446–56.PubMed Lorenzato A, et al. The cellular apoptosis susceptibility CAS/CSE1L gene protects ovarian cancer cells from death by suppressing RASSF1C. FASEB J. 2012;26(6):2446–56.PubMed
19.
go back to reference Dong Q, et al. Roles of the CSE1L-mediated nuclear import pathway in epigenetic silencing. Proc Natl Acad Sci USA. 2018;115(17):E4013–E40224022.PubMed Dong Q, et al. Roles of the CSE1L-mediated nuclear import pathway in epigenetic silencing. Proc Natl Acad Sci USA. 2018;115(17):E4013–E40224022.PubMed
20.
go back to reference Kutay U, et al. Export of importin alpha from the nucleus is mediated by a specific nuclear transport factor. Cell. 1997;90(6):1061–71.PubMed Kutay U, et al. Export of importin alpha from the nucleus is mediated by a specific nuclear transport factor. Cell. 1997;90(6):1061–71.PubMed
21.
go back to reference Ewings KE, Ryan KM. Hzf and hCAS/CSE1L: making the right choice in p53-mediated tumour suppression. Cell Res. 2007;17(10):829–31.PubMed Ewings KE, Ryan KM. Hzf and hCAS/CSE1L: making the right choice in p53-mediated tumour suppression. Cell Res. 2007;17(10):829–31.PubMed
22.
go back to reference Tanaka T, et al. hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes. Cell. 2007;130(4):638–50.PubMed Tanaka T, et al. hCAS/CSE1L associates with chromatin and regulates expression of select p53 target genes. Cell. 2007;130(4):638–50.PubMed
23.
go back to reference Zhu JH, et al. Suppression of cellular apoptosis susceptibility (CSE1L) inhibits proliferation and induces apoptosis in colorectal cancer cells. Asian Pac J Cancer Prev. 2013;14(2):1017–21.PubMed Zhu JH, et al. Suppression of cellular apoptosis susceptibility (CSE1L) inhibits proliferation and induces apoptosis in colorectal cancer cells. Asian Pac J Cancer Prev. 2013;14(2):1017–21.PubMed
24.
go back to reference Liao CF, et al. CSE1L, a novel microvesicle membrane protein, mediates Ras-triggered microvesicle generation and metastasis of tumor cells. Mol Med. 2012;18:1269–80.PubMedPubMedCentral Liao CF, et al. CSE1L, a novel microvesicle membrane protein, mediates Ras-triggered microvesicle generation and metastasis of tumor cells. Mol Med. 2012;18:1269–80.PubMedPubMedCentral
25.
go back to reference Xu R, et al. Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct. Methods. 2015;87:11–25.PubMed Xu R, et al. Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct. Methods. 2015;87:11–25.PubMed
26.
go back to reference Tai CJ, et al. Cellular apoptosis susceptibility (CSE1L/CAS) protein in cancer metastasis and chemotherapeutic drug-induced apoptosis. J Exp Clin Cancer Res. 2010;29(1):110.PubMedPubMedCentral Tai CJ, et al. Cellular apoptosis susceptibility (CSE1L/CAS) protein in cancer metastasis and chemotherapeutic drug-induced apoptosis. J Exp Clin Cancer Res. 2010;29(1):110.PubMedPubMedCentral
27.
28.
go back to reference Yuksel UM, et al. The relationship between CSE1L expression and axillary lymph node metastasis in breast cancer. Tumori. 2015;101(2):194–8.PubMed Yuksel UM, et al. The relationship between CSE1L expression and axillary lymph node metastasis in breast cancer. Tumori. 2015;101(2):194–8.PubMed
29.
go back to reference Liu C, et al. CSE1L participates in regulating cell mitosis in human seminoma. Cell Prolif. 2019;52(2):e12549.PubMed Liu C, et al. CSE1L participates in regulating cell mitosis in human seminoma. Cell Prolif. 2019;52(2):e12549.PubMed
30.
go back to reference Li Y, et al. CSE1L silence inhibits the growth and metastasis in gastric cancer by repressing GPNMB via positively regulating transcription factor MITF. J Cell Physiol. 2020;235(3):2071–9.PubMed Li Y, et al. CSE1L silence inhibits the growth and metastasis in gastric cancer by repressing GPNMB via positively regulating transcription factor MITF. J Cell Physiol. 2020;235(3):2071–9.PubMed
31.
go back to reference Liao CF, et al. CSE1L/CAS, the cellular apoptosis susceptibility protein, enhances invasion and metastasis but not proliferation of cancer cells. J Exp Clin Cancer Res. 2008;27:15.PubMedPubMedCentral Liao CF, et al. CSE1L/CAS, the cellular apoptosis susceptibility protein, enhances invasion and metastasis but not proliferation of cancer cells. J Exp Clin Cancer Res. 2008;27:15.PubMedPubMedCentral
32.
go back to reference Tang Z, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102.PubMedPubMedCentral Tang Z, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102.PubMedPubMedCentral
33.
go back to reference Gyorffy B, Schafer R. Meta-analysis of gene expression profiles related to relapse-free survival in 1,079 breast cancer patients. Breast Cancer Res Treat. 2009;118(3):433–41.PubMed Gyorffy B, Schafer R. Meta-analysis of gene expression profiles related to relapse-free survival in 1,079 breast cancer patients. Breast Cancer Res Treat. 2009;118(3):433–41.PubMed
34.
go back to reference Gyorffy B, et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat. 2010;123(3):725–31.PubMed Gyorffy B, et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat. 2010;123(3):725–31.PubMed
35.
go back to reference Mihaly Z, et al. A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer. Breast Cancer Res Treat. 2013;140(2):219–32.PubMed Mihaly Z, et al. A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer. Breast Cancer Res Treat. 2013;140(2):219–32.PubMed
36.
go back to reference Chandrashekar DS, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649–58.PubMedPubMedCentral Chandrashekar DS, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649–58.PubMedPubMedCentral
37.
go back to reference Tai CJ, et al. Increased cellular apoptosis susceptibility (CSE1L/CAS) protein expression promotes protrusion extension and enhances migration of MCF-7 breast cancer cells. Exp Cell Res. 2010;316(17):2969–81.PubMed Tai CJ, et al. Increased cellular apoptosis susceptibility (CSE1L/CAS) protein expression promotes protrusion extension and enhances migration of MCF-7 breast cancer cells. Exp Cell Res. 2010;316(17):2969–81.PubMed
38.
go back to reference Monian P, Jiang X. The cellular apoptosis susceptibility protein (CAS) promotes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis and cell proliferation. J Biol Chem. 2016;291(5):2379–88.PubMed Monian P, Jiang X. The cellular apoptosis susceptibility protein (CAS) promotes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis and cell proliferation. J Biol Chem. 2016;291(5):2379–88.PubMed
39.
go back to reference Baldin V, et al. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 1993;7(5):812–21.PubMed Baldin V, et al. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 1993;7(5):812–21.PubMed
40.
go back to reference Shivakumar L, et al. The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol Cell Biol. 2002;22(12):4309–18.PubMedPubMedCentral Shivakumar L, et al. The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol Cell Biol. 2002;22(12):4309–18.PubMedPubMedCentral
41.
go back to reference Behrens P, et al. Implication of the proliferation and apoptosis associated CSE1L/CAS gene for breast cancer development. Anticancer Res. 2001;21(4A):2413–7.PubMed Behrens P, et al. Implication of the proliferation and apoptosis associated CSE1L/CAS gene for breast cancer development. Anticancer Res. 2001;21(4A):2413–7.PubMed
42.
go back to reference Tung MC, et al. Higher prevalence of secretory CSE1L/CAS in sera of patients with metastatic cancer. Cancer Epidemiol Biomarkers Prev. 2009;18(5):1570–7.PubMed Tung MC, et al. Higher prevalence of secretory CSE1L/CAS in sera of patients with metastatic cancer. Cancer Epidemiol Biomarkers Prev. 2009;18(5):1570–7.PubMed
43.
go back to reference Ma S, et al. LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer. Aging. 2018;10(8):2062–78.PubMedPubMedCentral Ma S, et al. LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer. Aging. 2018;10(8):2062–78.PubMedPubMedCentral
44.
go back to reference Luo W, et al. 24-Hydroxylase in cancer: impact on vitamin D-based anticancer therapeutics. J Steroid Biochem Mol Biol. 2013;136:252–7.PubMed Luo W, et al. 24-Hydroxylase in cancer: impact on vitamin D-based anticancer therapeutics. J Steroid Biochem Mol Biol. 2013;136:252–7.PubMed
45.
go back to reference Horvath HC, et al. The candidate oncogene CYP24A1: a potential biomarker for colorectal tumorigenesis. J Histochem Cytochem. 2010;58(3):277–85.PubMedPubMedCentral Horvath HC, et al. The candidate oncogene CYP24A1: a potential biomarker for colorectal tumorigenesis. J Histochem Cytochem. 2010;58(3):277–85.PubMedPubMedCentral
46.
go back to reference Chen G, et al. CYP24A1 is an independent prognostic marker of survival in patients with lung adenocarcinoma. Clin Cancer Res. 2011;17(4):817–26.PubMed Chen G, et al. CYP24A1 is an independent prognostic marker of survival in patients with lung adenocarcinoma. Clin Cancer Res. 2011;17(4):817–26.PubMed
47.
go back to reference Sakakia T, et al. CYP24A1 as a potential target for cancer therapy. Anticancer Agents Med Chem. 2014;14:97–108. Sakakia T, et al. CYP24A1 as a potential target for cancer therapy. Anticancer Agents Med Chem. 2014;14:97–108.
48.
go back to reference Zhalehjoo N, Shakiba Y, Panjehpour M. Gene expression profiles of CYP24A1 and CYP27B1 in malignant and normal breast tissues. Mol Med Rep. 2017;15(1):467–73.PubMed Zhalehjoo N, Shakiba Y, Panjehpour M. Gene expression profiles of CYP24A1 and CYP27B1 in malignant and normal breast tissues. Mol Med Rep. 2017;15(1):467–73.PubMed
49.
go back to reference Osanai M, Lee GH. CYP24A1-induced vitamin D insufficiency promotes breast cancer growth. Oncol Rep. 2016;36(5):2755–62.PubMed Osanai M, Lee GH. CYP24A1-induced vitamin D insufficiency promotes breast cancer growth. Oncol Rep. 2016;36(5):2755–62.PubMed
50.
go back to reference Tourigny A, et al. CYP24A1 exacerbated activity during diabetes contributes to kidney tubular apoptosis via caspase-3 increased expression and activation. PLoS ONE. 2012;7(10):e48652.PubMedPubMedCentral Tourigny A, et al. CYP24A1 exacerbated activity during diabetes contributes to kidney tubular apoptosis via caspase-3 increased expression and activation. PLoS ONE. 2012;7(10):e48652.PubMedPubMedCentral
51.
go back to reference Mohri T, et al. MicroRNA regulates human vitamin D receptor. Int J Cancer. 2009;125(6):1328–33.PubMed Mohri T, et al. MicroRNA regulates human vitamin D receptor. Int J Cancer. 2009;125(6):1328–33.PubMed
Metadata
Title
Cellular apoptosis susceptibility protein (CAS) suppresses the proliferation of breast cancer cells by upregulated cyp24a1
Authors
Mei Ye
Ruigang Han
Jianwu Shi
Xunda Wang
Allan Z. Zhao
Fanghong Li
Hao Chen
Publication date
01-05-2020
Publisher
Springer US
Published in
Medical Oncology / Issue 5/2020
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-020-01366-w

Other articles of this Issue 5/2020

Medical Oncology 5/2020 Go to the issue